WallStreetZenWallStreetZen

NASDAQ: KRYS
Krystal Biotech Inc Stock Forecast, Predictions & Price Target

Analyst price target for KRYS

Based on 6 analysts offering 12 month price targets for Krystal Biotech Inc.
Min Forecast
$139.00+30.08%
Avg Forecast
$154.33+44.43%
Max Forecast
$160.00+49.73%

Should I buy or sell KRYS stock?

Based on 6 analysts offering ratings for Krystal Biotech Inc.
Strong Buy
Strong Buy
5 analysts 83.33%
Buy
1 analysts 16.67%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their KRYS stock forecasts and price targets.

KRYS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-11-20
lockedlocked$00.00+00.00%2023-11-07
lockedlocked$00.00+00.00%2023-10-12
lockedlocked$00.00+00.00%2023-09-07
lockedlocked$00.00+00.00%2023-08-08Find Out Why
HC Wainwright & Co.
Bottom 1%
1
BuyReiterates$139.00+30.08%2023-08-07

1 of 1

Forecast return on equity

Is KRYS forecast to generate an efficient return?
Company
N/A
Industry
-0.69%
Market
30.34%

Forecast return on assets

Is KRYS forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.29%

KRYS revenue forecast

What is KRYS's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$37.2M+334.78%
Avg 2 year Forecast
$183.7M+2,046.65%
Avg 3 year Forecast
$309.1M+3,512.12%
KRYS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

KRYS revenue growth forecast

How is KRYS forecast to perform vs Biotechnology companies and vs the US market?
Company
232.14%
Industry
34.65%
Market
7.68%
KRYS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
KRYS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

KRYS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
KRYS$106.86$154.33+44.43%Strong Buy
DNA$1.36$2.50+83.82%Hold
GPCR$61.87$86.50+39.81%Strong Buy
IMCR$57.99$79.40+36.92%Strong Buy
FOLD$11.22$17.00+51.52%Buy

Krystal Biotech Stock Forecast FAQ

Is Krystal Biotech Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NASDAQ: KRYS) stock is to Strong Buy KRYS stock.

Out of 6 analysts, 5 (83.33%) are recommending KRYS as a Strong Buy, 1 (16.67%) are recommending KRYS as a Buy, 0 (0%) are recommending KRYS as a Hold, 0 (0%) are recommending KRYS as a Sell, and 0 (0%) are recommending KRYS as a Strong Sell.

If you're new to stock investing, here's how to buy Krystal Biotech stock.

What is KRYS's revenue growth forecast for 2023-2025?

(NASDAQ: KRYS) Krystal Biotech's forecast annual revenue growth rate of 232.14% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 34.65%, and it is also forecast to beat the US market's average forecast revenue growth rate of 7.68%.

Krystal Biotech's revenue in 2023 is $8,556,000.On average, 4 Wall Street analysts forecast KRYS's revenue for 2023 to be $1,049,275,476, with the lowest KRYS revenue forecast at $770,032,809, and the highest KRYS revenue forecast at $1,421,599,032. On average, 4 Wall Street analysts forecast KRYS's revenue for 2024 to be $5,180,572,012, with the lowest KRYS revenue forecast at $2,905,251,990, and the highest KRYS revenue forecast at $8,224,965,828.

In 2025, KRYS is forecast to generate $8,717,250,905 in revenue, with the lowest revenue forecast at $7,079,788,830 and the highest revenue forecast at $10,770,869,174.

What is KRYS's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: KRYS) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.29%.

What is KRYS's Price Target?

According to 6 Wall Street analysts that have issued a 1 year KRYS price target, the average KRYS price target is $154.33, with the highest KRYS stock price forecast at $160.00 and the lowest KRYS stock price forecast at $139.00.

On average, Wall Street analysts predict that Krystal Biotech's share price could reach $154.33 by Nov 20, 2024. The average Krystal Biotech stock price prediction forecasts a potential upside of 44.43% from the current KRYS share price of $106.86.

What is KRYS's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: KRYS) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.